EcoDrugPlus

Bcl2 Apoptosis Regulator

Ensembl ID : ENSPLOG00000013394
Gene Symbol: BCL2
4 Cross references
227 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSPLOG00000011887
Gene Symbol: BCL2L1
4 Cross references
286 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSPLOG00000003483
Gene Symbol: BCL2L10
2 Cross references
129 Possible Orthologues:

Bcl2 Like 2

Ensembl ID : ENSPLOG00000012453
Gene Symbol: BCL2L2
4 Cross references
64 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSPLOG00000018206
Gene Symbol: BCR
4 Cross references
274 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSPLOG00000019188
Gene Symbol: BTK
2 Cross references
207 Possible Orthologues:

C-C Chemokine Receptor Type 5-Like

Ensembl ID : ENSPLOG00000002409
Gene Symbol: LOC122214262
3 Cross references
294 Possible Orthologues:

C-C Motif Chemokine Receptor 1

Ensembl ID : ENSPLOG00000002376
Gene Symbol: CCR1
2 Cross references
299 Possible Orthologues:

C-C Motif Chemokine Receptor 2

Ensembl ID : ENSPLOG00000002398
Gene Symbol: CCR2
3 Cross references
294 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSPLOG00000006627
Gene Symbol: CCR4
4 Cross references
254 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSPLOG00000002316
Gene Symbol: CCR9
4 Cross references
262 Possible Orthologues:

C-X-C Chemokine Receptor Type 2-Like

Ensembl ID : ENSPLOG00000021306
Gene Symbol: LOC122226628
3 Cross references
233 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).